Find your path to Teresa
148 people in our graph share verified history with Teresa — schools, employers, funds. One of them is your warm intro.
Ken HowardunlockedTeresa: together at UPMC (2013)
×8Teresa: together at University of Pittsburgh
×3Teresa: together at Baxter International Inc.
About
Teresa Whalen is a clinical pharmacist and life sciences investor who serves as CEO of CytoAgents, a company developing GP1681 as a treatment for Cytokine Release Syndrome across multiple indications. She is a board member at St. Clair Hospital in the Greater Pittsburgh area, where she sits on the Quality and Safety, Community Outreach, and Medical Staff Development committees, and a director on the board of Life Sciences Pennsylvania. She was recognized as part of EY Winning Women in 2021 and has funded and advised life sciences companies from startup through exit.
Chief Executive Officer at CytoAgents
Intro paths
→
In turn, Teresa can intro founders to CytoAgents's investors below.
CytoAgents's investors · 2
Experience
- Life Sciences PennsylvaniaDirector Board of Directorscurrent2026 — presentPittsburgh, PA
- Allegheny Conference on Community DevelopmentMember Board of Directorscurrent2024 — presentPittsburgh, Pennsylvania, United States
- CytoAgentsCEOcurrent2018 — presentGreater Pittsburgh Area
- St. Clair HospitalMember Board Of Directorscurrent2019 — presentGreater Pittsburgh Area
- Next Act Fund LLCMember, Investment Committee Co-Chaircurrent2018 — presentGreater Pittsburgh Area
- BlueTree Venture FundLife Sciences Investorcurrent2018 — present
- ExcellenceRxCEO2017 — 2018Greater Pittsburgh Area
- NTT DATA Global Solutions CorporationSVP Strategic Partnerships/Senior Director2013 — 2017Greater Pittsburgh Area
- UPMCPharmacist2010 — 2013Mercy Hospital, Level 1 Trauma Center and Comprehensive Burn Center
- McKessonClinical Specialty Pharmacist2008 — 2009Greater Pittsburgh Area
- Baxter International Inc.Sales Manager of Pioneering Products: Intellifill IV Robot and DoseEdge: ForHealth Technologies2004 — 2008Greater Pittsburgh Area/NorthEast US/Formerly ForHealth Technologies
- Siemens HealthcareZone Sales Manager, Clinical Solutions1995 — 2004NorthEast United States
- UPMCPharmacist1991 — 1995Greater Pittsburgh Area
Skills & more
Biotechnology11Drug Development8Infectious Diseases6Life Sciences1Pharmaceutics1Pharmacology1Product Development1Public Health1Investments1Go-to-market Strategy1Healthcare15Healthcare Information Technology13
+10 more
HospitalsInformaticsHealthcare ManagementPatient SafetyPharmacyHealthcare ConsultingHealthcare IndustryHealthcare Information Technology (HIT)Strategic PlanningMentoringLanguages English
- Registered Pharmacist, RPh
From Teresa's professional profile.
Frequently asked questions
- Who is Teresa Whalen, RPh?
- Teresa Whalen is a clinical pharmacist and life sciences investor who serves as CEO of CytoAgents, a company developing GP1681 as a treatment for Cytokine Release Syndrome across multiple indications. She is a board member at St. Clair Hospital in the Greater Pittsburgh area, where she sits on the Quality and Safety, Community Outreach, and Medical Staff Development committees, and a director on the board of Life Sciences Pennsylvania. She was recognized as part of EY Winning Women in 2021 and has funded and advised life sciences companies from startup through exit.
- Where does Teresa Whalen, RPh work?
- Teresa Whalen, RPh is Chief Executive Officer at CytoAgents.
- Where did Teresa Whalen, RPh go to school?
- Teresa Whalen, RPh studied at University of Pittsburgh (Bachelor of Science (B.S.), Pharmacy).
Founder mafias
University of Pittsburgh mafia53
Also came through, then founded or led a company.
Gatumi AliyuBachelor of Science - BSFounded Stack Diagnostics +2Taylor LowePhilosophyFounded Metal +1Younghyun ChungDoctor of Philosophy (Ph.D.)Founded Corca +1Lia WinterBioengineering and Biomedical EngineeringFounded Winter Innovations +1Dave ColaizziBAFounded Signature Diagnostics +1Brett CrosbyPolitical ScienceFounded PeerStreet +1
+ 46 more
UPMC mafia12
Also came through, then founded or led a company.
Paulo FontesProfessor of Surgery, Director Machine Perfusion Program, Department of Surgery, STI, UPMCFounded VirTech Bio +1Imran CronkSummer Associate - Supply Chain ManagementFounded Ride Health +1Troy DemmerStrategic PlanningFounded Gecko RoboticsNeil BatlivalaStudent Medical ShadowerFounded Pair TeamTim KeaneClinical Biomedical Engineer, Artificial Heart ProgramFounded TYBR HealthDr. Hanadie YousefUndergraduate ResearcherFounded Juvena Therapeutics
+ 5 more
Same school
Also attended University of Pittsburgh128
Yervand SarkisyanInvestor in deep tech and AIJon KaplanExecutive Venture Partner at Caduceus Capital PartnersSalvador GalaCo-founder & Managing Partner at Ev3 Ventures LlcJustin MaresBuilding companies at the intersection of health and technology.Kelly BarnumDirector Of Talent at Volition CapitalMatt GurinDirector, Finance and Operations at RRE Ventures
+ 122 more
Shared employers
Also worked at Next Act Fund LLC2
Also worked at UPMC15
Ken HowardVice President of Technology Services at Flare Capital PartnersTiziana RossettiPrincipal, Telethon Strategy at Sofinnova PartnersSanjay MistryVice President, Venture Investments, New Company Creation at Johnson & Johnson Innovation – JJDCTroy DemmerFounder/COO at Gecko RoboticsStefano GridelliFounder/CEO at NetBeezNeil BatlivalaFounder at Pair Team
+ 9 more
Also worked at McKesson39
Tod PessesInvestor at Silversmith Capital PartnersJake FosterSpecial Operator, Technology at Level EquityJason ShookChief Operating Officer at Oncology VenturesDiana VerrilliGeneral Manager, Navista (a Cardinal Health company) at Oncology VenturesKendra PerlitzChief Operating Officer at Playground GlobalChing-Ping LinPartner & COO at Orbit Startups
+ 33 more
Also worked at Baxter International Inc.55
Brian CheeManaging Partner at Polaris PartnersNick RoelofsVenture Partner at ScietyBengt JulanderSenior Advisor at ScietyRamanathan VStartup Ecosystem Builder at SeafundJulie KimRepresentative Director – President and CEO at Takeda VenturesKavita BjörkdahlInvestor at Almi Invest
+ 49 more